Andrew Assalian

Andrew Assalian is currently the Group Account Director at Kadiko, a business transformation agency. Previously, they held the position of Director of Marketing at IPC The Hospitalist Company, where they led market expansion efforts, and worked as a Product Marketing Manager for Enbrel at Immunex Corp., contributing to the success of a groundbreaking biologic drug. Earlier in their career, they served as a Marketing Manager at Remedy Partners, focusing on value-based payment models in healthcare, and were a Laboratory Manager at The Wistar Institute. They earned a Bachelor of Science in Biology from the State University of New York College of Environmental Science and Forestry.